Review Article| Volume 26, ISSUE 2, P387-395, June 2006

Fungi as Bioweapons

      Fungi cause disease directly by infection or indirectly through mycotoxins. Fungi that are used as weapons might be targeted against humans, livestock, or crops. Humans and animals encounter fungi and mycotoxins through inhalation, ingestion, and contact with skin and mucous membranes. Effective fungal bioweapons would require the ability to cause significant destruction and a means of delivery to target populations or farms. Effective countermeasures against fungal bioweapons would be able to prevent or treat this damage. This article describes several potential biological warfare or bioterrorism fungal species and mycotoxins in regard to their biology, epidemiology, potential for weaponization, and the clinical features, prevention, and treatment of the diseases that they cause.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. CDC Select Agent Program. List of select agents and toxins. Available at: Accessed January 27, 2006.

        • Dixon D.M.
        Coccidioides immitis as a select agent of bioterrorism.
        J Appl Microbiol. 2001; 91: 602-605
        • Kwon-Chung K.J.
        • Bennett J.E.
        in: Medical mycology. Lea & Febiger, Malvern (PA)1992: 356-396
      2. US Department of Health and Human Services Centers for Disease Control and Prevention and National Institutes of Health. Biosafety in microbiological and biomedical laboratories. Available at: Accessed January 27, 2006.

        • Chiller T.M.
        • Galgiani J.N.
        • Stevens D.A.
        Infect Dis Clin North Am. 2003; 17: 41-57
        • Galgiani J.N.
        West J Med. 1993; 159: 153-171
        • Deresinski S.
        Coccidioides immitis as a potential bioweapon.
        Semin Respir Infect. 2003; 18: 216-219
        • Cox R.A.
        • Magee D.M.
        Coccidioidomycosis: host response and vaccine development.
        Clin Microbiol Rev. 2004; 17: 804-839
        • Cole G.T.
        • Xue J.M.
        • Okeke C.N.
        • et al.
        A vaccine against coccidioidomycosis is justified and attainable.
        Med Mycol. 2004; 42: 189-216
        • Galgiani J.N.
        • Ampel N.M.
        • Blair J.E.
        • et al.
        Clin Infect Dis. 2005; 41: 1217-1223
        • Bennett J.W.
        • Klich M.
        Clin Microbiol Rev. 2003; 16: 497-516
        • Etzel R.A.
        JAMA. 2002; 287: 425-427
        • Logrieco A.
        • Arrigan D.W.
        • Brengel-Pesce K.
        • et al.
        DNA arrays, electronic noses and tongues, biosensors and receptors for rapid detection of toxigenic fungi and mycotoxins: a review.
        Food Addit Contam. 2005; 22: 335-344
        • Koch P.
        State of the art of trichothecenes analysis.
        Toxicol Lett. 2004; 153: 109-112
        • McGovern T.W.
        • Christopher G.W.
        • Eitzen E.M.
        Cutaneous manifestations of biological warfare and related threat agents.
        Arch Dermatol. 1999; 135: 311-322
        • Rocha O.
        • Ansari K.
        • Doohan F.M.
        Effects of trichothecene mycotoxins on eukaryotic cells: a review.
        Food Addit Contam. 2005; 22: 369-378
        • Steyn P.S.
        Mycotoxins, general view, chemistry and structure.
        Toxicol Lett. 1995; 82–83: 843-851
        • Bhat R.V.
        • Beedu S.R.
        • Ramakrishna Y.
        • et al.
        Outbreak of trichothecene mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India.
        Lancet. 1989; 1: 35-37
      3. Outbreaks of gastrointestinal illness of unknown etiology associated with eating burritos–United States, October 1997–October 1998.
        MMWR Morb Mortal Wkly Rep. 1999; 48: 210-213
        • Franz D.R.
        • Jahrling P.B.
        • Friedlander A.M.
        • et al.
        Clinical recognition and management of patients exposed to biological warfare agents.
        JAMA. 1997; 278: 399-411
        • Etzel R.A.
        • Montana E.
        • Sorenson W.G.
        • et al.
        Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrysatra and other fungi.
        Arch Pediatr Adolesc Med. 1998; 152: 757-762
      4. Update. Pulmonary hemorrhage/hemosiderosis among infants–Cleveland, Ohio, 1993–1996.
        MMWR Morb Mortal Wkly Rep. 2000; 49: 180-184
      5. Update. Pulmonary hemorrhage/hemosiderosis among infants–Cleveland, Ohio, 1993–1996.
        MMWR Morb Mortal Wkly Rep. 1997; 46: 33-35
        • Fairhurst S.
        • Maxwell S.A.
        • Scawin J.W.
        • et al.
        Skin effects of trichothecenes and their amelioration by decontamination.
        Toxicology. 1987; 46: 307-319
        • Mutoh A.
        • Ishii K.
        • Ueno Y.
        Effects of radioprotective compounds and anti-inflammatory agents on the acute toxicity of trichothecenes.
        Toxicol Lett. 1988; 40: 165-174
      6. Marasas WFO, Miller JD, Riley RT, et al. Environmental Health Criteria 219: Fumonisin B1. Available at: Accessed January 27, 2006.

        • Stevens V.L.
        • Tang J.
        Fumonisin B1-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor.
        J Biol Chem. 1997; 272: 18020-18025
        • Williams J.H.
        • Phillips T.D.
        • Jolly P.E.
        • et al.
        Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions.
        Am J Clin Nutr. 2004; 80: 1106-1122
        • Zilinskas R.A.
        Iraq's biological weapons. The past as future?.
        JAMA. 1997; 278: 418-424
        • Stone R.
        Biodefense. Peering into the shadows: Iraq's bioweapons program.
        Science. 2002; 297: 1110-1112